A. M. Pappas & Associates logo

A. M. Pappas & Associates

North America, North Carolina, United States, Durham

Description

AMP, a California-based start-up building audio processing technologies to empower people to hear better in their everyday lives.

Investor Profile

A. M. Pappas & Associates has made 19 investments, with 0 in the past 12 months and 11% as lead.

Stage Focus

  • Series B (26%)
  • Series A (21%)
  • Series Unknown (16%)
  • Series E (11%)
  • Series C (11%)
  • Undisclosed (5%)
  • Post Ipo Equity (5%)
  • Series D (5%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Health Diagnostics
  • Pharmaceutical
  • Medical Device
  • Life Science
  • Therapeutics
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does A. M. Pappas & Associates frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 3
Domain Associates
North America, California, United States, San Diego
Co-Investments: 3
Sprout Group
North America, New York, United States, New York
Co-Investments: 2
U.S. Bancorp
North America, Minnesota, United States, Minneapolis
Co-Investments: 2
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 2
Advent International
North America, Massachusetts, United States, Boston
Co-Investments: 2
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 3
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 3
GeneChem
North America, Quebec, Canada, Montréal
Co-Investments: 2

Which angels does A. M. Pappas & Associates often collaborate with?

Shared Deals: 1

What are some of recent deals done by A. M. Pappas & Associates?

CeNeRx BioPharma

Cary, North Carolina, United States

CeNeRx BioPharma, a drug development company, engages in developing therapeutics to treat diseases related to the nervous system.

BiopharmaBiotechnologyTherapeutics
Series BSep 29, 2008
Amount Raised: $15,000,000
Cerexa Inc.

New York, New York, United States

Cerexa is a biopharmaceutical company produces a portfolio of anti-infective therapies for the treatment of life-threatening infections.

BiotechnologyHealth CareMedicalPharmaceutical
Series AAug 23, 2005
Amount Raised: $50,000,000
BrainCells

San Diego, California, United States

BrainCells is a biotechnology startup focused on drugs intended to stimulate the growth of new neurons.

BiotechnologyHealth CareMedical Device
Series AJul 15, 2005
Amount Raised: $17,700,000
Asstrodyne TDI

Mansfield, Massachusetts, United States

Astrodyne TDI designs and manufactures power and EMI filter solutions.

BiopharmaBiotechnologyManufacturingPharmaceutical
Series CMay 13, 2005
Amount Raised: $26,400,000
Plexxikon

Berkeley, California, United States

Plexxikon is a engages in the discovery and development of small molecule pharmaceuticals to treat human disease.

BiotechnologyHealth CareMedical
Series BMay 26, 2004
Amount Raised: $46,000,000
Panacos Pharmaceuticals

Watertown, Massachusetts, United States

Panacos Pharmaceuticals a drug company focused on HIV and other major human viral diseases.

BiotechnologyHealth CareMedical Device
Post Ipo EquityMay 18, 2004
Amount Raised: $18,300,000
Peninsula Pharmaceuticals

Alameda, California, United States

A bio­pharmaceuti­cal company focused on the devel­opment and com­mer­cializa­tion of antibi­otics.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsMedical
Series CJan 16, 2004
Amount Raised: $57,900,000
Selventa

Cambridge, Massachusetts, United States

Selventa offers scientific consulting services, licensed software products and strategic partnerships for the medical sector.

BiotechnologyHealth CareHealth Diagnostics
Series ASep 8, 2003
Amount Raised: $6,500,000
LipoScience

Raleigh, North Carolina, United States

LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology.

BiotechnologyHealth CareHealth DiagnosticsLife Science
Series EAug 7, 2003
Amount Raised: $15,000,000
Emerald BioAgriculture Corporation

Okemos, Michigan, United States

Emerald BioAgriculture Corporation is a privately held company that develops biochemical products to increase crop production.

AgricultureBiopharmaBiotechnology
Series UnknownJan 29, 2003
Amount Raised: $6,200,000